Surveying Open Trials Of Chimeric Antigen Receptor Therapy
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Research in CAR immunotherapy for cancer is concentrated at a small number of academic centers and the National Cancer Institute, with some 30 trials open.